Over Active Bladder
Pipeline by Development Stage
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (12)
Total enrollment: 5,313 patients across 12 trials
A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment
Fesoterodine "add-on" Male Overactive Bladder Study
Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome
Evaluation Of The Ability Of Fesoterodine To Increase Urethral Pressure In Stress Urinary Incontinence Patients
A Study to Assess the Cognitive Effects of Fesoterodine in Elderly Subjects
The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects
A Bioequivalence Study Of 4 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy Subjects
BlueWind Medical System for the Treatment of Patients With OAB
Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder
Non-Interventional Study To Investigate Whether Information Provided To Patients Influences Their Satisfaction With Toviaz Therapy
Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous Therapy
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.